Primary focal segmental glomerulosclerosis: clinical course and response to therapy (Q40762562)

23 September 2017

1 reference

title

Primary focal segmental glomerulosclerosis: clinical course and response to therapy (English)

1 reference

focal segmental glomerulosclerosis

23 September 2017

1 reference

Korbet SM

1

1 reference

PubMed ID

8203357

23 September 2017

Schwartz MM

series ordinal

2

1 reference

PubMed ID

8203357

23 September 2017

Lewis EJ

series ordinal

3

1 reference

23 September 2017

1 June 1994

1 reference

American Journal of Kidney Diseases

23 September 2017

1 reference

23 September 2017

23

1 reference

23 September 2017

773-783

1 reference

23 September 2017

6

1 reference

Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Clinicopathological study of nephrotic syndrome in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Editorial: Focal glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Primary focal segmental glomerulosclerosis: pathology, histological variants, and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Adult lipoid nephrosis: clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal glomerular sclerosis: contrasting clinical patterns in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

The prognosis of focal segmental glomerular sclerosis of adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal sclerosing glomerulopathy risk factors of progression and optimal mode of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal sclerosing glomerulonephropathy with hyalinosis. A clinical and pathologic analysis of the disease in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

The significance of focal sclerotic lesions of glomeruli in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Primary nephrosis in childhood associated with focal glomerular sclerosis: is long-term prognosis that severe?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal segmental glomerulosclerosis with and without nephrotic syndrome in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Focal segmental glomerular sclerosis: the cellular lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

The glomerular tip lesion: a previously undescribed type of segmental glomerular abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Further studies on the glomerular tip lesion: early and late stages and life table analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Ciclosporin in the treatment of nephrosis. Minimal change disease and focal-segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Treatment of severe nephrotic syndrome with meclofenamate: an uncontrolled pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Meclofenamate Treatment of Recurrent Idiopathic Nephrotic Syndrome With Focal Segmental Glomerulosclerosis After Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Recurrent nephrotic syndrome in renal allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

Ciclosporin in idiopathic nephrotic syndrome of children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980128-4

7 January 2021

10.1016/S0272-6386(12)80128-4

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8203357